Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Former 10% Owner
-
Issuer Symbol
-
BIOA on Nasdaq
There are no Buy or Sell transactions made by Cormorant Asset Management, LP since 15 Feb 2025
Holdings reported by Cormorant Asset Management, LP for BioAge Labs, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1,629,529 |
$29,331,522 |
$18.00 |
27 Sep 2024 |
Indirect |
|
|
| Series D Redeemable Convertible Preferred Stock |
0 |
|
|
27 Sep 2024 |
Indirect |
Common Stock |
|
Transactions reported by Cormorant Asset Management, LP for BioAge Labs, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.